BioCentury
ARTICLE | Emerging Company Profile

Replay: a genetic medicines tool kit that includes HSV vectors

Start-up is advancing multiple platforms and programs through a hub-and-spoke model

July 25, 2022 11:03 PM UTC

Replay has assembled a genetic medicines tool kit that includes a large-cargo HSV vector platform with which it hopes to address unmet needs in eye, skin, brain and muscle diseases.

Backed by $55 million in seed funding led by KKR and OMX Ventures, Replay Holdings LLC is advancing its programs with a hub-and-spoke model that co-founding CEO Lachlan MacKinnon said is “designed to separate technology development from product development.”...

BCIQ Company Profiles

Replay Holdings LLC